Key Takeaways
Aehr Test Systems, a maker of semiconductor test equipment, saw its shares jump 36.3% this week after securing a new customer in the supply chain for artificial intelligence data centers, confirming the company's role in the buildout of AI infrastructure.
"This order is another strong signal of Aehr’s solution for AI end-markets and confirmatory of our thesis," a William Blair analyst team led by Jed Dorsheimer wrote on Tuesday, adding that they have been expecting AI customers to flock to Aehr.
The stock rose 47.2% over a three-day period, its best such stretch since July 2025, bringing its year-to-date gain to 119.5%. The rally began after Aehr announced an initial order from a “major supplier to the data center optical transceiver market” for testing its silicon photonics-based devices. William Blair analysts estimate the initial order is valued at approximately $10 million.
This new business provides a crucial foothold in the rapidly expanding market for high-speed components essential for AI and cloud data centers. While investors are cheering the long-term growth prospects, Aehr faces a challenging near-term, with Wall Street expecting the company to report a 41% year-over-year revenue decline and a loss for its fiscal third quarter on Tuesday.
The order is for Aehr's systems that perform wafer-level test and burn-in, a critical stress-testing process that ensures the reliability of silicon photonics integrated circuits. These circuits are fundamental to the optical interconnects used in data center networking and emerging optical I/O for AI processors, which require massive amounts of data to be moved quickly and efficiently.
The customer, which remains unnamed, is developing these components to meet the “rapidly accelerating demand for high-speed fiberoptic communication links in hyperscale AI and cloud data centers,” according to Aehr. Analysts speculate the customer could be a top-tier supplier such as Cisco Systems, Broadcom, or Marvell Technology. The systems are scheduled to ship in Aehr’s fiscal fourth quarter, which ends in May 2026.
The announcement prompted a bullish response from William Blair, which sees the potential for significant follow-on business. The firm believes Aehr could announce an additional $30 million to $50 million in orders within the next two months. "We expect the cadence of AI-related order wins to accelerate and catalyze shares," Dorsheimer wrote.
This positive outlook for new orders contrasts sharply with the consensus forecast for Aehr's upcoming earnings report. Analysts expect revenue of just $10.8 million and a loss of seven cents per share, a stark reversal from the seven-cent profit reported a year ago. The market's enthusiastic reaction to the new order suggests investors are prioritizing the company's strategic wins in the high-growth AI sector over its near-term financial performance. While smaller than broad-based test equipment providers like Teradyne, Aehr's specialized focus on wafer-level burn-in for silicon carbide and silicon photonics is now seen as a key advantage.
This article is for informational purposes only and does not constitute investment advice.
